MEDsan — Home of the iSelfTest Learn more

Shop our latest products! Learn more

Whole Blood Tests

  • Complete Blood Count (CBC) with Differential

    Hematocrit; hemoglobin; mean corpuscular volume (MCV); mean corpuscular hemoglobin (MCH); mean corpuscular hemoglobin concentration (MCHC); red cell distribution width (RDW); percentage and absolute differential counts; platelet count (RBC); red cell count; white blood cell count (WBC)

  • Complete Blood Count (CBC) without Differential

    Hematocrit; hemoglobin; MCH; MCHC; MCV; RDW; red blood cell count (RBC); platelet count; white blood cell count (WBC)

  • Neutrophil to Lymphocyte Ratio (NLR), Complete Blood Count (CBC) with Differential and Platelet

    NLR (Neutrophil to Lymphocyte Ratio) is a biomarker that can be used as an indication of subclinical inflammation. NLR is a calculation based on the Absolute Neutrophil Count divided by the Absolute Lymphocyte Count determined by the peripheral blood CBC differential. This calculation, according to recent literature, is useful in assessing the likelihood of severe progression of disease in SARS-CoV-2 positive patients.

    CBC: A screening test to evaluate overall health; detect and or identify a wide range of hematologic disorders; assist in managing medications and/or chemotherapeutic decisions.

  • Platelet Count

    Evaluate, diagnose, and/or follow up bleeding disorders, drug-induced thrombocytopenia, idiopathic thrombo-cytopenia purpura (acute or chronic), disseminated intravascular coagulation, leukemia states, chemotherapeutic management of malignant disease states; investigate purpura, petechiae; evaluate response to platelet transfusions, steroids, or other therapy

  • Epstein-Barr Virus (EBV)

    Epstein-Barr Virus (EBV), Quantitative, DNA PCR, Whole Blood

    This test is intended to be used for the quantitative detection of Epstein-Barr virus (EBV) DNA and as an aid in the diagnosis and management of EBV infections.

  • Interferon-γ Receptor Deficiency: Two-gene Profile (IFNGR1, IFNGR2) Full Gene Sequencing

    Confirm a clinical diagnosis of IFNGR; guide therapy; detect carriers; allow early diagnosis in family members.

    This test covers all coding nucleotides of genes IFNGR1 and FNGR2, plus at least two and typically 20 flanking intronic nucleotides upstream and downstream of each coding exon, covering the conserved donor and acceptor splice sites, as well as typically 20 flanking nucleotides in the 5′ and 3′ UTR.